Month: June 2025

Geneva, Switzerland, June 18, 2025 – Addex Therapeutics (SIX/NASDAQ: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, today announced that it will issue its Q1 2025 Financial Results on June 19, 2025. Tim Dyer, CEO and Mikhail Kalinichev, Head of Translational Science, will provide a business update and review of the Addex product pipeline during a teleconference and webcast for investors, analysts and media at 16:00 CEST (15:00 BST / 10:00 EDT / 07:00 PDT) the same day. Title:   Addex Therapeutics Q1 2025 financial results and corporate update Date: June 19, 2025Time: 16:00 CEST (15:00 BST / 10:00 EDT / 07:00 PDT) Joining the Conference Call:Participants are required to register in advance of the conference using the link...

SIKA STRENGTHENS GLOBAL PRESENCE WITH STRATEGIC INVESTMENTS ACROSS ALL REGIONS Sika continues to deliver on its Local-for-Local strategy with the launch of three new manufacturing investments in China, Brazil, and Morocco—reinforcing its commitment to serving customers with local production, global expertise, and sustainable innovation. By expanding its footprint in these markets, Sika is actively executing its growth strategy—strengthening its global presence and laying the groundwork for future expansion. These site developments are part of a broader effort to increase market penetration, and ensure that production capabilities are aligned with customer needs at a regional level. In the fast-growing metropolitan hub of Suzhou, Sika has extended its existing site to support China’s urban development. Serving a region of more than 12...

REDWOOD CITY, Calif., June 17, 2025 (GLOBE NEWSWIRE) — Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity company, today announced the pricing of its previously announced underwritten public offering consisting of (i) 19,450,000 shares of its common stock and accompanying warrants to purchase an aggregate of 19,450,000 shares of common stock (or pre-funded warrants in lieu thereof) and (ii) in lieu of common stock, to certain investors, pre-funded warrants to purchase an aggregate of up to 550,000 shares of its common stock and accompanying warrants to purchase an aggregate of 550,000 shares of common stock (or pre-funded warrants in lieu thereof), at an exercise price of $0.0001 per pre-funded warrant. In addition, Biomea has granted the underwriters a 30-day option to purchase up to an additional...

～Record Participation for SBC Medical. 22 doctors Present Insights in Their Respective Fields～ IRVINE, Calif., June 17, 2025 (GLOBE NEWSWIRE) — SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical”) today announced that a total of 22 representatives, including Yoshiyuki Aikawa, CEO of SBC Medical, and doctors from Shonan Beauty Clinic, a clinic operated under the management support of SBC Medical Group, a consolidated subsidiary, presented their research findings at “The 113th Congress of Japan Society of Aesthetic Surgery.” Yoshiyuki Aikawa, CEO of SBC Medical Group Holdings Incorporated The Japan Society of Aesthetic Surgery (JSAS), one of Japan’s leading professional societies in the field of aesthetic medicine, brings together doctors dedicated to shaping the future of the industry. “The 113th Congress of Japan...

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAW CALGARY, Alberta, June 17, 2025 (GLOBE NEWSWIRE) — High Arctic Overseas Holdings Corp. (TSXV: HOH) (“High Arctic Overseas” or the “Corporation”) announced today that the TSX Venture Exchange (the “Exchange”) has accepted a notice filed by the Corporation of its intention to make a Normal Course Issuer Bid (the “Bid”) to be transacted through the facilities of the Exchange. The notice provides that the Corporation may, during the 12-month period commencing June 20, 2025 and ending June 19, 2026 purchase up to 622,408 Common Shares (“Shares”) in total, being approximately 5% of the total number...

GUANGZHOU, China, June 18, 2025 (GLOBE NEWSWIRE) — EHang Holdings Limited (Nasdaq: EH) (“EHang” or the “Company”), the world’s leading Urban Air Mobility (“UAM”) technology platform company, today announced the expansion of its strategic partnership with Gotion High-Tech Co., Ltd. (“Gotion”), a leading innovator in power battery solutions. Building on a power system framework agreement signed in December 2023, this enhanced collaboration marks a significant step forward in powering the electric vertical take-off and landing (“eVTOL”) aircraft. Under the upgraded partnership, the two companies will jointly advance the development of power systems for EHang’s flagship EH216 series of pilotless eVTOL aircraft, with plans to extend their collaboration to future aircraft models. By leveraging cutting-edge battery technologies, the partnership...

BROOKLYN, N.Y., June 17, 2025 (GLOBE NEWSWIRE) — Pioneer Acquisition I Corp (Nasdaq: PACHU) (the “Company”) announced today the pricing of its initial public offering of 22,000,000 units at $10.00 per unit. The units are expected to be listed on the Nasdaq Global Market (“Nasdaq”) and trade under the ticker symbol “PACHU” beginning June 18, 2025. Each unit consists of one Class A ordinary share and one-half of one redeemable warrant. Once the securities comprising the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on Nasdaq under the symbols “PACH” and “PACHW”, respectively. The underwriter has been granted a 45-day option to purchase up to an additional 3,300,000 units offered by the Company to cover over-allotments, if any. The offering is expected to close on June 20, 2025, subject...

NEWPORT BEACH, Calif., June 17, 2025 (GLOBE NEWSWIRE) — GivBux, Inc. (OTC: GBUX), a publicly traded Super App and charitable giving platform, today announced it has finalized the agreement to acquire Charter House Financial AU. The transaction will be completed by July 13, 2025 provided definitive Share Exchange Agreement whereby GivBux acquired 100% of the issued and outstanding shares of Charter House Ltd. in exchange for shares of GivBux common stock. By partnering with GivBux, the Charter House plans to expand participation in gold-backed financial benefits through the GivBux Super App. By integrating Charter House with the GivBux platform, it will help broaden access to gold-backed benefits for users. The hope is that operating Charter House as a wholly owned subsidiary it will generate multiple revenue streams. The founder...

HUNTSVILLE, June 17, 2025 (GLOBE NEWSWIRE) — This press release has been updated to reflect the correct timing of the funding round. Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform™ drug optimization technology, today congratulates its strategic partner and largest shareholder, Juvenescence Ltd., on the $76 million first tranche close of its targeted $150 million Series B financing, as well as its new strategic partnership with M42, a global tech-enables health company headquartered in Abu Dhabi. “Juvenescence has been a critical partner to Serina, providing strategic guidance and capital that have helped us advance our POZ Platform™ into the clinic,” said Steve Ledger, Chief Executive Officer of Serina Therapeutics. “We congratulate...